Breaking News
January 18, 2019 - New study shows link between secondhand smoke and cardiac arrhythmia
January 18, 2019 - DZIF scientists reveal problems with available diagnostics for Zika and chikungunya virus
January 18, 2019 - Breast cancers more likely to metastasize in young women within 10 years of giving birth
January 18, 2019 - Blood vessels can now be created perfectly in a petri dish
January 18, 2019 - Study identifies prominent socioeconomic and racial disparities in health behavior in Indiana
January 18, 2019 - Young-Onset Type 2 Diabetes Tied to Increased Hospitalization Risk
January 18, 2019 - For-profit nursing schools associated with lower performance on nurse licensure test
January 18, 2019 - Considering the culture of consent in medicine
January 18, 2019 - Researchers identify comprehensive guidelines for managing severe atopic dermatitis
January 18, 2019 - Analyzing proteins in blister fluid may classify burn severity more accurately
January 18, 2019 - Study finds higher suicide rates among youth who were Medicaid enrollees
January 18, 2019 - Opioid drugs often overprescribed to children for pain relief, say CHOP surgeons
January 18, 2019 - New biodegradable wound dressing material accelerates healing
January 18, 2019 - Life in Space May Take Toll on Spinal Muscles
January 18, 2019 - Bulldogs’ screw tails linked to human genetic disease
January 18, 2019 - Immunotherapy target identified for pediatric cancers
January 18, 2019 - Financial stress may increase heart disease risk in African Americans
January 18, 2019 - Scientists solve another piece of Ebola virus puzzle
January 18, 2019 - New project finds how endocrine disruptors interfere with thyroid functions
January 18, 2019 - Research finds decline in ketone body utilization when coronary circulation is reduced
January 18, 2019 - Let’s map our DNA and save billions each year in health costs
January 18, 2019 - AI demonstrates potential to identify irregular heart rhythms as well as humans
January 17, 2019 - Study shows link between air pollution and increased risk of sleep apnea
January 17, 2019 - Neck-strengthening exercises can protect athletes from concussions
January 17, 2019 - Computer model shows how to better control MRSA outbreaks
January 17, 2019 - Pain is unpleasant, and now scientists have identified the set of responsible neurons
January 17, 2019 - CUIMC Celebrates 2018-2019
January 17, 2019 - Study reveals potential pathway for endothelial cells to avoid apoptosis
January 17, 2019 - Hamilton Storage launches LabElite DeCapper SL to expand LabElite product family
January 17, 2019 - Location of epigenetic changes co-locate with genetic signal causing psychartric disorder
January 17, 2019 - Researchers awarded 6.1 million euros to address female fertility problems
January 17, 2019 - Counseling appointments fail to reduce weight gain during pregnancy, shows study
January 17, 2019 - Contraceptive patch that could provide 6 months of contraception within seconds
January 17, 2019 - Yeast model may pave way for development of novel therapies for metabolic disorders
January 17, 2019 - Study determines impact of antibiotic perturbation of the gut microbiome on skeletal health
January 17, 2019 - Cardiometabolic Risk Up With Tourette, Chronic Tic Disorder
January 17, 2019 - Hong Kong scientists claim ‘broad-spectrum’ antiviral breakthrough
January 17, 2019 - Researchers discover the brain cells that make pain unpleasant | News Center
January 17, 2019 - Hepatitis Is Common in New Cancer Patients
January 17, 2019 - Podcast: KHN’s ‘What The Health?’ Drug Prices Are Rising Again. Is Someone Going To Do Something About It?
January 17, 2019 - Smoking significantly increases your biological age, study shows
January 17, 2019 - B-group vitamins may be beneficial for people with first episode psychosis
January 17, 2019 - Researchers demonstrate how manganese produces parkinsonian syndrome
January 17, 2019 - Researchers suggest link between personality type and attitude towards others’ bodies
January 17, 2019 - Mutant mice administered with cocaine failed to exhibit hyperactivity, shows study
January 17, 2019 - Health Tip: Understanding a Heart Murmur
January 17, 2019 - Gut protein mutations shield against spikes in glucose
January 17, 2019 - Engineered immune cells target broad range of pediatric solid tumors in mice | News Center
January 17, 2019 - Study provides comprehensive description of associations between mental disorders
January 17, 2019 - Study finds link between high pesticide exposure and poor sense of smell among farmers
January 17, 2019 - Many cancer patients have undiagnosed hepatitis
January 17, 2019 - New study finds only 13% of outpatient antibiotic prescriptions to be appropriate
January 17, 2019 - Stem cell-based approach to diabetes offers hope for treatment
January 17, 2019 - New project receives €8.65 million from EU and Canada to ease genomic, health data sharing
January 17, 2019 - Improvements in pharmacological study to fight cognitive impairment in schizophrenia
January 17, 2019 - Study looks at trends over time in oral antibiotic prescribing by dermatologists
January 17, 2019 - Most substance use disorder treatment facilities do not offer medication treatment
January 17, 2019 - Multiple sclerosis could benefit from stem cell therapy
January 17, 2019 - Researchers manipulate T cells to improve transplant success
January 17, 2019 - Put away your rulers and reach for your phone
January 17, 2019 - Mindfulness linked with fewer menopausal symptoms
January 17, 2019 - Integrated care to women with PMADs offered at several levels
January 17, 2019 - Researchers identify MANF as a rejuvenating factor in parabiosis
January 17, 2019 - Truncal mutations study suggests new direction in origins of cancer
January 17, 2019 - Beckman Coulter launches new ClearLLab 10C System for clinical flow cytometry lab
January 17, 2019 - Effects of linoleic acid on the body are largely dependent on genes, shows study
January 17, 2019 - Pre-injury exercise reduces damage to both muscles and nerves, study finds
January 17, 2019 - Minimizing Antibody Size to Maximize Research Potential
January 17, 2019 - Research finds large genome in tiny forest defoliator
January 17, 2019 - Technology helps reduce the yearning for unhealthy food
January 17, 2019 - Imec develops prototype cardiovascular device
January 17, 2019 - New Drug Application for Insomnia Disorder Treatment Lemborexant Submitted in the United States
January 17, 2019 - What you should know about teeth whitening
January 17, 2019 - Why Older Adults Should Eat More Protein (And Not Overdo Protein Shakes)
January 17, 2019 - Colorectal cancer mortality rates predicted to increase globally
January 17, 2019 - Scientists discover mutational signatures of tumor hypoxia
January 17, 2019 - New evidence shows how fever alters immune cells
January 17, 2019 - Researchers find new class of blood pressure-regulating peptides in vampire bat venom
January 17, 2019 - Promega to exhibit new Maxwell RSC48 platform at 2019 Festival of Genomics
January 17, 2019 - Study pinpoints immune cells that could be key to tackling hypertension
Tailored drug cocktails offer hope to kids with aggressive brain tumors

Tailored drug cocktails offer hope to kids with aggressive brain tumors

image_pdfDownload PDFimage_print

UCSF Benioff Children’s Hospitals are harnessing next-generation genomic technology to develop individualized drug cocktails in a new trial for children with a type of malignant brain tumor. This precision-medicine approach offers a new strategy in the treatment for high-grade glioma, an intractable brain cancer in which survival has plateaued for decades.

In the trial, UCSF Health neuro-oncologist Sabine Mueller, MD, Ph.D., and her colleagues in the Pacific Pediatric Neuro-Oncology Consortium (PNOC) will treat up to 44 children and young adults. Patients will be enrolled at UCSF Benioff Children’s Hospital San Francisco and other sites in the 18-hospital PNOC network, which is tasked with translating new findings in cancer biology to more effective therapies.

The drug cocktails will be developed with up to four therapies specifically targeted to the child’s tumor. Each will be screened using the UCSF 500 Cancer Gene Panel, which flags the most common cancer genetic mutations; and molecular profiling and analysis services provided by NantHealth, Inc. (NASDAQ: NH), which includes whole-genome and whole-exome sequencing for all DNA and genes, detecting any changes that promote cancer growth; as well as RNA sequencing, which offers important clues about the cancer gene expression and gene fusions that drive cancer progression.

The trial will be offered for patients with high-grade glioma that includes anaplastic astrocytoma, glioblastoma and midline high-grade glioma, all of which are aggressive forms of brain tumor with few current therapeutic options.

“While survival for some childhood cancers has been improving since the 1970s, this has not happened for some solid tumors, including types of pediatric brain tumors,” said Mueller, who is the project leader for PNOC.

“We have learned a lot about the molecular makeup of high-grade gliomas in recent years and we recognize that their heterogeneity means that a blanket treatment approach fails to reach most patients,” she said. “We hope that this personalized strategy may lead the way to life-saving treatments for children with high-grade gliomas, as well as other treatment-resistant brain tumors.”

Approximately 10 percent of the 4,610 tumors of the brain and central nervous system diagnosed each year in U.S. children and teens are high-grade gliomas, with two-year survival ranging from about 35 percent to less than 10 percent, Mueller said. While surgical techniques for brain tumors have improved over the years, some high-grade gliomas are inoperable or cannot be totally removed. Chemotherapy and radiation may extend survival, but in many cases the tumors remain resistant to long-term remission.

Standard Therapy Not Effective for Curbing Disease

Typically, when a child with high-grade glioma experiences tumor growth or recurrence, oncologists may propose different chemotherapy agents or re-irradiation following surgery, Mueller said, “But these therapies may be incompatible with the tumor’s unique biology and may do nothing to curb disease, while causing debilitating side effects.”

In the trial, researchers will analyze samples of tumor in a specialized lab and “read” the genetic makeup of both the tumor and normal cells using a DNA sequencer. Any genetic alterations may be matched with existing targeted therapies or investigational new drug study agents that block the growth of cancer by interfering with the molecular targets that drive progression.

“One of the pitfalls in identifying the drugs best suited for each child is that many therapies fail to cross the blood-brain barrier or have a high enough concentration to cause a biological effect,” said Michael Prados, MD, a neuro-oncologist at UCSF Benioff Children’s Hospitals and founder and co-project leader of PNOC.

“We are working with drugs that have demonstrated blood-brain barrier penetration, based upon laboratory findings or prior clinical studies,” Prados said. “However, anticipating delivery across the blood-brain barrier is different than actually knowing its impact in an individual patient. UCSF Benioff Children’s Hospitals, together with PNOC, will be studying this further in an upcoming trial.”

Scientists also will examine the DNA sequence in healthy cells to see if there are germline or heritable mutations that increase the risk for other cancers.

“We are pleased that the molecular profiling and analysis technology that drives our GPS Cancer product will be used to support important research in pediatric brain cancer,” said Patrick Soon-Shiong, MD, chairman and CEO of NantHealth. “By sequencing the entire genome, this technology ensures the most comprehensive and actionable data about the biology of the tumor will be available to the oncologist before treatment begins. The application in this study is of particular interest because there are generally fewer DNA mutations in pediatric cancers than in adult variations.”

A parallel trial is underway at UCSF Benioff Children’s Hospital San Francisco and other PNOC sites for children with the most virulent high-grade glioma, known as diffuse intrinsic pontine glioma (DIPG), using a similar precision medicine approach. Despite decades of research, the average survival for DIPG is less than one year.


Explore further:
Scientists target glioma cancer stem cells, which could improve patient survival

Provided by:
University of California, San Francisco

Tagged with:

About author

Related Articles